There are 2934 resources available
4517 - Updated results of the PARP1/2 inhibitor pamiparib in combination with low-dose (ld) temozolomide (TMZ) in patients (pts) with locally advanced or metastatic solid tumors
Presenter: Agostina Stradella
Session: Poster Discussion – Developmental therapeutics
Resources:
Abstract
Invited Discussant LBA1 and LBA2_PR
Presenter: Ana Oaknin
Session: Presidential Symposium I
Resources:
Slides
Webcast
Invited Discussant LBA4_PR
Presenter: Sanjay Popat
Session: Presidential Symposium I
Resources:
Slides
Webcast
Invited Discussant LBA5_PR
Presenter: Pasi Jänne
Session: Presidential Symposium I
Resources:
Slides
Webcast
Welcome and introduction
Presenter: Luis Paz-Ares
Session: Novartis Oncology - Removing the brakes on the immune system: Gearing up for tumor-promoting inflammation inhibitors in NSCLC
Resources:
Webcast
Immunotherapy in the rearview mirror: Successes and remaining unmet needs
Presenter: Alistair Greystoke
Session: Novartis Oncology - Removing the brakes on the immune system: Gearing up for tumor-promoting inflammation inhibitors in NSCLC
Resources:
Webcast
Navigating towards the future of immunotherapy
Presenter: Edward Garon
Session: Novartis Oncology - Removing the brakes on the immune system: Gearing up for tumor-promoting inflammation inhibitors in NSCLC
Resources:
Webcast
Interleukin-1: gearing up in NSCLC
Presenter: Luis Paz-Ares
Session: Novartis Oncology - Removing the brakes on the immune system: Gearing up for tumor-promoting inflammation inhibitors in NSCLC
Resources:
Webcast
Summary and close
Presenter: Luis Paz-Ares
Session: Novartis Oncology - Removing the brakes on the immune system: Gearing up for tumor-promoting inflammation inhibitors in NSCLC
Resources:
Webcast
Setting the scene: The patient perspective
Presenter: Ananda Plate
Session: Fertility and pregnancy of cancer patients during and after treatment
Resources:
Slides
Webcast